Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen

BACKGROUND: Increasing evidence suggests that glucagon-like peptide 1 (GLP-1) receptor agonists (RA) can stabilize glycemic variability (GV) and interfere with eating behavior. This study compared the impact of insulin, GLP-1 RA, and dietary components on GV using professional continuous glucose mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Hsuan, Lin, Chia-Hung, Huang, Yu-Yao, Chen, Hsin-Yun, Tai, An-Shun, Fu, Shih-Chen, Hsieh, Sheng-Hwu, Sun, Jui-Hung, Chen, Szu-Tah, Lin, Sheng-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719195/
https://www.ncbi.nlm.nih.gov/pubmed/36463197
http://dx.doi.org/10.1186/s40001-022-00892-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719195/
https://www.ncbi.nlm.nih.gov/pubmed/36463197
http://dx.doi.org/10.1186/s40001-022-00892-9

Ejemplares similares